Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Lozenges for Smokeless Tobacco Addiction
NCT00392379Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by Mayo Clinic. Started Jan 2007; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00392379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392379.